Ralinepag, Ralinepag, Ralinepag, Ralinepag
ROR-PH-303
Phase 3 small_molecule active
Quick answer
Ralinepag, Ralinepag, Ralinepag, Ralinepag for Pulmonary arterial hypertension (PAH) is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Pulmonary arterial hypertension (PAH)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active